| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 07/13/2005 | EP1552004A2 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 07/13/2005 | EP1552003A1 Methods to assess quality of microarrays |
| 07/13/2005 | EP1552001A2 Methods and compositions for detecting targets |
| 07/13/2005 | EP1551979A2 Compositions and methods for treatment and detection of multiple cancers |
| 07/13/2005 | EP1551972A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 07/13/2005 | EP1551964A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 07/13/2005 | EP1551859A2 Aav itr-mediated modulation |
| 07/13/2005 | EP1390710A4 Amplification and detection of $i(mycoplasma pneumoniae) |
| 07/13/2005 | EP1383923A4 High-fidelity dna sequencing using solid phase capturable dideoxynucleotides and mass spectrometry |
| 07/13/2005 | EP0681431B1 Production of human recombinant collagen in the milk of transgenic animals |
| 07/13/2005 | CN1639570A Proteins with repetitive bacterial-ig-like (BIG) domains present in leptospira species |
| 07/13/2005 | CN1639355A Double and triple readout assay systems |
| 07/13/2005 | CN1639352A Amplifying repetitive nucleic acid sequences |
| 07/13/2005 | CN1639349A Microorganisms and processes for enhanced production of pantothenate |
| 07/13/2005 | CN1639328A Novel dehydrogenase and gene encoding the same |
| 07/13/2005 | CN1639320A Cold shock inducible expression and production of heterologous polypeptides |
| 07/13/2005 | CN1639183A Secretion, transcription and sporulation genes in bacillus clausii |
| 07/13/2005 | CN1638799A Human mast cell-expressed membrane proteins |
| 07/13/2005 | CN1637143A Correlation gene for generating synthetic cholesterol synthetic inhibitor monakalin k |
| 07/13/2005 | CN1637019A Vascular adhesion molecules and modulation of their function |
| 07/13/2005 | CN1637014A Dendrimer-based DNA extraction methods and biochips |
| 07/13/2005 | CN1637013A Modified cpg oligodeoxynucleotide with improved immunoregulatory function |
| 07/13/2005 | CN1636594A Angiostatin and use of the same for inhibition of angiogenesis |
| 07/13/2005 | CN1210290C Delivery of nucleic acids |
| 07/13/2005 | CN1210288C Method of extracting DNA from spermatophore of fish |
| 07/12/2005 | US6917616 Method and apparatus for reduction and restoration of data elements pertaining to transmitted data packets in a communications network |
| 07/12/2005 | US6916971 Comprises nucleotide sequences coding glutamic acid transfer RNA reductase for identifying effective nontoxic herbicides; enzyme inhibitors |
| 07/12/2005 | US6916917 Chimeric pro-caspases and methods of using same |
| 07/12/2005 | US6916915 Comprises nucleotide sequences coding beta adrenergic receptor kinase for use as tool in drug screening and discovery |
| 07/12/2005 | US6916913 Dorsalin-1 polypeptide and uses thereof |
| 07/12/2005 | US6916904 Inhibition of immune complex formation |
| 07/12/2005 | US6916794 Method of enhancing drainage of lacrimal system with purinergic receptor agonists |
| 07/12/2005 | US6916786 Especially Keratinocyte Growth Factor 12; accelerating wound healing and treating gastrointestinal and respiratory disorders. |
| 07/12/2005 | US6916653 Ribozymal nucleic acid |
| 07/12/2005 | US6916648 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/12/2005 | US6916644 Genetic engineered protein; controlling cell proliferation, cell differentiation |
| 07/12/2005 | US6916625 Artery- and vein-specific proteins and uses therefor |
| 07/12/2005 | US6916616 Stabilized aqueous nucleoside triphosphate solutions |
| 07/12/2005 | US6916612 Sets of oligonucleotide-binding e-tag probes |
| 07/12/2005 | US6916610 Method for generation of longer cDNA fragments from sage tags for gene identification |
| 07/12/2005 | US6916609 Comprises nucleotide sequences coding chaperone protein for diagnosis, prevention and treatment of cancer, immunological and inflammatory diseases |
| 07/12/2005 | US6916606 Electrochemiluminescent assays |
| 07/12/2005 | US6916603 Administering a test agent; monitoring expression of Delta FosB to determine whether the agent modulates bone formation |
| 07/12/2005 | US6916474 Binds immunologically to bacillus anthracis protective antigen with an affinity kd of 140-21 pm determined by surface plasmon resonance |
| 07/07/2005 | WO2005061734A2 Double stranded linear nucleic acid probe and uses thereof |
| 07/07/2005 | WO2005061733A1 Preparation of defined highly labeled probes |
| 07/07/2005 | WO2005061722A1 Nucleic acid amplification methods |
| 07/07/2005 | WO2005061710A1 Oligomeric compounds for the modulation of bcl-2 |
| 07/07/2005 | WO2005061548A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins. |
| 07/07/2005 | WO2005060721A2 Manipulation of rna interference through modulation of armitage activity |
| 07/07/2005 | WO2005060675A2 Novel spliced 5-ht1a receptors and methods, kits, and uses relating thereto |
| 07/07/2005 | WO2005060642A2 Rationally designed antibodies |
| 07/07/2005 | WO2005060618A2 Enzyme-free isothermal exponential amplification of nucleic acids and nucleic acid analog signals |
| 07/07/2005 | WO2005060553A2 Geraniol synthase, methods of production and uses thereof |
| 07/07/2005 | WO2005060375A2 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein |
| 07/07/2005 | WO2005054518A3 Compositions and their uses directed to bone growth modulators |
| 07/07/2005 | WO2005038006A3 Chimeric metabotropic glutamate receptors and uses thereof |
| 07/07/2005 | WO2005038003A3 Compositions and methods for generation of positive and negative selection vectors |
| 07/07/2005 | WO2005033284A3 Compositions and methods for gene expression |
| 07/07/2005 | WO2005032461A3 Novel peptide with osteogenic activity |
| 07/07/2005 | WO2005023979A3 Isolated s. mansoni nucleic acid molecules and uses thereof |
| 07/07/2005 | WO2005019419A3 Co-detection of single polypeptide and polynucleotide molecules |
| 07/07/2005 | WO2005016966A3 Intron fusion proteins, and methods of identifying and using same |
| 07/07/2005 | WO2005003293A3 pRNA CHIMERA |
| 07/07/2005 | WO2004092340A3 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 07/07/2005 | WO2004080425A3 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 07/07/2005 | WO2004052290A3 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 07/07/2005 | WO2004046160A8 Amino-lna, thio-lna and alpha-l-oxy-ln |
| 07/07/2005 | WO2004003233A8 Methods to assess quality of microarrays |
| 07/07/2005 | US20050149994 Rapidly maturing fluorescent proteins and methods for using the same |
| 07/07/2005 | US20050148662 compounds possess the ability to recognize and promote oxidation and allow for scission of a nucleic acid at specific positions and splitting (if exposed to piperidine) |
| 07/07/2005 | US20050148540 P1,P4-di(uridine 5'-)tetraphosphate, tetrasodium salt; in a pharmaceutically acceptable carrier for treating retinal detachment, dry eye |
| 07/07/2005 | US20050148537 Immunostimulatory nucleic acid molecules |
| 07/07/2005 | US20050148535 Inducing apoptosis in cancer cells; expression vectors, cells; kits |
| 07/07/2005 | US20050148533 Modulation of RANKL expression |
| 07/07/2005 | US20050148531 Antisense agents; blocking agents (biotin); high throughput screening |
| 07/07/2005 | US20050148530 useful in modulating vascular endothelial growth factor (VEGF) and/or vascular endothelial growth factor receptor (e.g., VEGFR) gene expression; used in therapeutic, diagnostic, target validation, and genomic discovery |
| 07/07/2005 | US20050148527 Catalytic nucleic acids; ribozymes; translation inhibition; gene expression inhibition; for treating cardiovascular disease; for neovascularization induction in heart tissue |
| 07/07/2005 | US20050148526 Methods of obtaining isoform specific expression in mammalian cells |
| 07/07/2005 | US20050148525 Nucleic acid markers |
| 07/07/2005 | US20050148514 Method and composition for treatment of angiogenesis |
| 07/07/2005 | US20050148513 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 07/07/2005 | US20050148511 Fibroblast growth factor (FGF); enhanced receptor subtype specificity and/or affinity; for treatment of skeletal dysplasia, osteoporosis and enhancing bone fracture healing and cartilage healing processes; mitogens |
| 07/07/2005 | US20050148509 Insulin-like growth factor; fusion proteins; chimera; apoptosis |
| 07/07/2005 | US20050148506 Novel method of modulating bone-related activity |
| 07/07/2005 | US20050148505 Genes and agents to regulate follicular development, ovulation cycle and steriodogenesis |
| 07/07/2005 | US20050148087 Isobarically labeled analytes and fragment ions derived therefrom |
| 07/07/2005 | US20050148067 Materials and methods for binding nucleic acids to surfaces |
| 07/07/2005 | US20050148045 Using transgenic microorganism comprising gene coding fostriecin polyketide synthase to generates antitumor antibiotics; bioreactors; anticarcinogenic agents |
| 07/07/2005 | US20050148035 fusion proteins comprising insulin-like growth factor binding protein-3 fragments of human native-sequence, linked to a synthetic polypetide, used in cell-based assays, as IGF antagonists, in mapping IGF binding sites on other molecules such as wild-type IGFBP-3 and IGF agonist peptides |
| 07/07/2005 | US20050148030 Using computer generated models to design immunoglobulin specific ligands; immunosuppressants; rational drug design |
| 07/07/2005 | US20050148027 Very large scale immobilized polymer synthesis |
| 07/07/2005 | US20050148015 Nucleic acid fragments for the identification of dechlorinating bacteria |
| 07/07/2005 | US20050148011 Mixture comprising nucleic acid-modifying enzyme for use in chromatographic or electrophoretic analysis |
| 07/07/2005 | US20050148010 Tracer reagents that enhance reaction-product analysis |
| 07/07/2005 | US20050148009 Tracer reagents that enhance reaction-product analysis |
| 07/07/2005 | US20050148002 Sequence of surface immobilized polymers utilizing microfluorescence detection |
| 07/07/2005 | US20050147997 Blocking group(s) is released by reaction with trigger (phosphatase); optionally contains urea-containing group for attaching proteins, peptides or nucleic acids; rhodamine; kits |
| 07/07/2005 | US20050147993 Recombinant high mobility polypeptide comprisingprotein transduction domain linked to non-nuclear organelle targeting signal; gene transfer vector |
| 07/07/2005 | US20050147988 Recombinant protein for use as tool in detection of helicobacter infection; immunodiagnostics |